GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe.

GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative.

GSK aims to expand its Stevenage facility to create one of the largest life sciences sites in Europe. The future of the giant drug maker is at stake as its boss faces one of her biggest challenges.